Actively Recruiting

Age: 18Years - 120Years
All Genders
NCT06519747

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

Led by Population Health Research Institute · Updated on 2024-11-07

750

Participants Needed

6

Research Sites

115 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

CONDITIONS

Official Title

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

Who Can Participate

Age: 18Years - 120Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Underwent noncardiac surgery within the past 72 hours
  • Surgery required or expected to require an overnight hospital admission or caused significant physiological stress
  • Meets one of these high-risk criteria:
    • Age 55-64 with cardiovascular disease, recent major vascular surgery, CHA2DS2-VASc score ≥3, or elevated post-op troponin
    • Age 65-74 with cardiovascular disease, recent major vascular surgery, CHA2DS2-VASc score ≥2, or elevated post-op troponin
    • Age 75 or older
  • Provided written informed consent to participate
Not Eligible

You will not qualify if you...

  • History of chronic atrial fibrillation before noncardiac surgery
  • Need for long-term systemic anticoagulation
  • Ongoing need for long-term dual antiplatelet treatment
  • Contraindication to oral anticoagulation
  • Severe renal insufficiency
  • Severe liver cirrhosis
  • Acute stroke in past 14 days
  • Underwent cardiac surgery in past 35 days
  • History of nontraumatic intracranial, intraocular, or spinal bleeding
  • Hemorrhagic disorder or bleeding diathesis
  • Known life expectancy less than 1 year due to other diseases
  • Women who are pregnant, breastfeeding, or of childbearing potential not using effective contraception
  • Expected non-compliance with follow-up or device use
  • Known allergy to monitoring device or its components
  • Previously enrolled in DETECT-POAF study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Hamilton General Hospital

Hamilton, Ontario, Canada, L8L 2X2

Actively Recruiting

2

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, Canada, L8N 4A6

Not Yet Recruiting

3

Juravinski Hospital

Hamilton, Ontario, Canada, L8V 1C3

Actively Recruiting

4

London Health Sciences Centre - University Hospital

London, Ontario, Canada, N6A 5A5

Not Yet Recruiting

5

Niagara Health System - St. Catharine's Site

St. Catharines, Ontario, Canada, L2S 0A9

Not Yet Recruiting

6

Hôpital Fleurimont du Centre hospitalier universitaire de Sherbrooke

Sherbrooke, Quebec, Canada, J1H 5H3

Not Yet Recruiting

Loading map...

Research Team

V

Vitheya Thanabalan

CONTACT

K

Kate Brady

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here